Effects of antiarrhythmic drugs on apoptotic pathways in H9c2 cardiac cells

Journal of Pharmacological Sciences

Volumn 101, Issue 4, 2006, Pages 318-324

  Isomoto, Shojiro ^a,b   Kawakami, Atsushi ^b   Arakaki, Tatsuya ^a   Yamashita, Shunichi ^b   Yano, Katsusuke ^b   Ono, Katsushige ^a  

^a OITA UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Amiodarone; Antiarrhythmic drug; Apoptosis; H9c2 cell

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NIFEKALANT; PILSICAINIDE; PROPRANOLOL; VERAPAMIL;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART MUSCLE CELL; NONHUMAN;

EID: 33747822935     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0050951     Document Type: Article

References (33)

1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-257.
2. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-1462.
3. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182-1189.
4. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM. Apoptosis in human acute myocardial infarction. Circulation. 1997;95:320-323.
5. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
6. Arola OJ, Saraste A, Pulkki K, Kallajoki M, Parvinen M, Voipio-Pulkki LM. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res. 2000;60:1789-1792.
7. Wu S, Ko YS, Teng MS, Ko YL, Hsu LA, Hsueh C, et al. Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies. J Mol Cell Cardiol. 2002;34:1595-1607.
8. Vaughan Williams EM. A classification of antiarrhythmic agents reassessed after a decade of new drugs. J Clin Pharmacol. 1984;24:129-147.
9. The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. Circulation. 1991;84:1831-1851.
10. Choi BY, Kim HY, Lee KH, Cho YH, Kong G. Clofilium, a potassium channel blocker, induces apoptosis of human promyelocytic leukemia (HL-60) cells via Bcl-2-insensitive activation of caspase-3. Cancer Lett. 1999;147:85-93.
11. Wei L, Yu SP, Gottron F, Snider BJ, Zipfel GJ, Choi DW. Potassium channel blockers attenuate hypoxia- and ischemia-induced neuronal death in vitro and in vivo. Stroke. 2003;34:1281-1286.
12. Balakumaran A, Campbell GA, Moslen MT. Calcium channel blockers induce thymic apoptosis in vivo in rats. Toxicol Appl Pharmacol. 1996;139:122-127.
13. Karwatsky J, Lincoln MC, Georges E. A mechanism for P-glycoprotein- mediated apoptosis as revealed by verapamil hypersensitivity. Biochemistry. 2003;42:12163-12173.
14. Goldenberg I, Grossman E, Jacobson KA, Shneyvays V, Shainberg A. Angiotensin II-induced apoptosis in rat cardiomyocyte culture: a possible role of AT1 and AT2 receptors. J Hypertens. 2001;19:1681-1689.
15. 2+-calpain and caspase-3 dependent pathway. Pharmacol Res. 2003;48:571-578.
16. Kimes BW, Brandt BL. Properties of a clonal muscle cell line from rat heart. Exp Cell Res. 1976;98:367-381.
17. Liu J, Yoshikawa H, Nakajima Y, Tasaka K. Involvement of mitochondrial permeability transition and caspase-9 activation in dimethyl sulfoxide-induced apoptosis of EL-4 lymphoma cells. Int Immunopharmaco. 2001;1:63-74.
18. Isomoto S, Konoe A, Centurion OA, Hayano M, Kaibara M, Hirata T, et al. Electrophysiological effects of MS-551 in humans: a class III antiarrhythmic agent. Pacing Clin Electrophysiol. 1995;18:2022-2027.
19. Sato T, Mitamura H, Kurita Y, Takeshita A, Shinagawa K, Miyoshi S, et al. Electropharmacologic effects of pilsicainide, a pure sodium channel blocker, on the remodeled atrium subjected to chronic rapid pacing. J Cardiovas Pharmacol. 2001;38:812-820.
20. Roden DM. Antiarrhythmic drugs. In: Hardman JG, Linbird LE, Gilman AG, editors. Goodman and Gilman's the pharmacological basis of therapeutics. 7th ed. New York: Macmillan; 2001. p. 933-970.
21. Kawakami A, Urayama S, Yamasaki S, Hida A, Miyashita T, Kamachi M, et al. Anti-apoptogenic function of TGFβ1 for human synovial cells: TGFβ1 protects cultured synovial cells from mitochondrial perturbation induced by several apoptogenic stimuli. Ann Rheum Dis. 2004;63:95-97.
22. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet. 1997;350:1417-1424.
23. Connolly SJ. Evidence-based analysis of amiodarone efficacy and safety. Circulation. 1999;100:2025-2034.
24. Bargout R, Jankov A, Dincer E, Wang R, Komodromos T, Ibarra-Sunga O, et al. Amiodarone induces apoptosis of human and rat alveolar epithelial cells in vitro. Am J Physiol. 2000;278:L1039-L1044.
25. Di Matola T, D'Ascoli F, Fenzi G, Rossi G, Martino E, Bogazzi F, et al. Amiodarone induces cytochrome c release and apoptosis through an iodine-independent mechanism. J Clin Endocrinol Metab. 2000;85:4323-4330.
26. Kaufmann P, Torok M, Hanni A, Roberts P, Gasser R, Krahenbuhl S. Mechanisms of benzarone and benzbromarone-induced hepatic toxicity. Hepatology. 2005;41:925-935.
27. Varbiro G, Toth A, Tapodi A, Bognar Z, Veres B, Sumegi B, et al. Protective effect of amiodarone but not N-desethyl-amiodarone on postischemic hearts through the inhibition of mitochondrial permeability transition. J Pharmacol Exp Ther. 2003;307:615-625.
28. Gotzsche LS, Pedersen EM. Dose-dependent cardiotoxic effect of amiodarone in cardioplegic solutions correlates with loss of dihydropyridine binding sites: in vitro evidence for a potentially lethal interaction with procaine. J Cardiovasc Pharmacol. 1994;23:13-23.
29. 2+ exchange current in guinea-pig cardiac myocytes. Br J Pharmacol. 2000;131:80-84.
30. Ide T, Tsutsui H, Kinugawa S, Utsumi H, Takeshita A. Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action. Circulation. 1999;100:690-692.
31. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol. 1999;144:281-292.
32. Lassus P, Opitz-Araya X, Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science. 2002;297:1352-1354.
33. Chipuk JE, Green DR. Do inducers of apoptosis trigger caspase-independent cell death? Nat Rev Mol Cell Biol. 2005;6:268-275.